Anti-HIV activity and mechanism of action of macrocyclic diamide SRR-SB3

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 12, 1998, Pages 1339-1342

  Mahmood, Naheed ^b   Jhaumeer Lauloo, Sabina ^a   Sampson, Julia ^b   Houghton, Peter J ^b  

^a UNIVERSITY OF MAURITIUS   (Mauritius)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIAMIDE; SRR SB3; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZAMIDE DERIVATIVE; DISULFIDE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG MECHANISM; MACROPHAGE; T LYMPHOCYTE; DRUG EFFECT; DRUG POTENTIATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIOLOGICAL EXAMINATION;

ANTI-HIV AGENTS; BENZAMIDES; DISULFIDES; DRUG SYNERGISM; HIV-1; MICROBIAL SENSITIVITY TESTS; ZIDOVUDINE;

EID: 0032233069     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03356.x     Document Type: Article

References (17)

1. Berenbaum, M. C. (1989) What is synergy? Pharmacol. Rev. 41: 93-141
2. Brinkworth, R. I., Fairlie, D. P. (1992) Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates. Biochem. Biophys. Res. Commun. 188: 624-630
3. Ferns, R. B., Tedder, R. S., Weiss, R. A. (1987) Characterization of monoclonal antibodies against the HIV gag products and their use in monitoring HIV isolate variation. J. Gen. Virol. 68: 1543-1551
4. Mahmood, N. (1995) Cellular assays for anti-viral drugs. A practical approach. In: Karn, J. (ed.) Biochemistry, Molecular Biology and Drug Discovery. HIV Vol. 2, pp 271-287
5. Mahmood, N., Jhaumeer-Lauloo, S., Khan, A., Burke, A., Chambers, P., Ramadas, S. R., Hay, A. J. (1995) Presented in the MRC AIDS Directed Programme Workshop, UK.
6. Mertens, A., Zilch, H., Konig, B., Schafer, W., Seidel, H., Leser, U., Leinert, H. (1993) Selective non-nucleoside HIV-1 RT inhibitors: new 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity. J. Med. Chem. 36: 2526-2535
7. Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., Schellekens, K., Janssen, M. A. C., DeClercq, E., Janssen, P. A. G. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343: 470-473
8. Rice, W. G., Schaeffer, C. A., Harten, B., Villinger, F., South, T. L., Summers, M. F., Henderson, L. E., Bess, J. W. J., Arther, L. O., McDougal, J. S., Orloff, S. L., Mendeleyev, J., Kun, E. (1993) Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361: 473-475
9. Rice, W. G. et al (1995) Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270: 1194-1197
10. Rice, W. G., Turpin, J. A., Haung, M., Clanton, D., Buckheit Jr, R. W., Covell, D. G., Wallqvist, A., McDonnell, N. B., DeGuzman, R. N., Summers, M. F., Zalkow, L., Bader, J. P., Haugwitz, R. D., Sausville, E. A. (1997) Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Medicine 3: 341-345
11. Roberts, N. A. et al (1990) Rational design of peptide-based HIV proteinase. Science 248: 358-361
12. Suhnel, J. (1990) Evaluation of synergism or antagonism for the combined action of antiviral agents. Antiviral Res. 13: 23-40
13. Tummino, P. J., Scholten, J. D., Harvey, P. J., Holler, T. P., Maloney, L., Gogliotti, R., Domagala, J., Hupr, D. (1996) The in vitro ejection of zinc from HIV type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proc. Natl Acad. Sci. USA 93: 969-973
14. Turpin, J. A., Terpening, S. J., Schaeffer, C. A., Yu, G., Glover, C. J., Felsted, R. L., Sausville, E. A., Rice, W. G. (1996) Inhibitors of human immunodeficiency virus type 1 zinc ringers prevent normal processing of Gag precursors and result in the release of noninfectious virus particles. J. Virol. 70: 6180-6189
15. 3 pocket of the enzyme. Biochem. Biophys. Res. Commun. 221: 815-820
16. Weislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H., Boyd, M. R. (1989) New soluble formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral-activity. J. Natl Cancer Inst. 81: 577-586
17. Witvrouw, M., Balzarini, J., Pannecouque, C., Jhaumeer-Lauloo, S., Este, J. A., Schols, D., Cherepanov, P., Schmit, J. C., Debyser, Z., Vandamme, A. M., Desmyter, J., Ramadas, S. R., DeClercq, E. (1997) SRR-SB3, a disulfide containing macrolide diamide that inhibits a late stage of the replicative cycle of HIV. Antimicrob. Agents Chemother. 41: 262-268